The two-year, $825,000 grant, awarded by the U.S. Department of Labor’s Employment and Training Administration, will be used to increase access to job training, internships and referrals across the state through the Military Outreach and Veterans Engagement (MOVE) initiative, launched in 2019 by the North Carolina Biotechnology Center.  ..read more

is rehearsing the overture of its avant-garde therapeutic platform targeting chronic Hepatitis B Virus (HBV) that could also upend many more chronic disease treatments. Tune, which is jointly based in Durham and Seattle, is one of a small group of gene therapy companies developing a new technology known as epigenetic editing ..read more

Grifols acquired the Johnston County facility in 2011 from Talecris Biotherapeutics, turning Grifols into a top-three plasma-sector powerhouse.  ..read more

Grifols acquired the Johnston County facility in 2011 from Talecris Biotherapeutics, turning Grifols into a top-three plasma-sector powerhouse.  ..read more

Sam Archer earned a B.S. in Biomedical Engineering from North Carolina Agriculture and Technical State University in Greensboro. Today, he works in quality assurance for Merck, a global biopharmaceutical company with a biomanufacturing site in Durham ..read more

About 1,300 people are expected to attend the global conference, which will explore topics of biopesticides, biostimulants, biofertilizers and other bioag tools important for farmers across the globe.  ..read more

The North Carolina Biotechnology Center has helped hundreds of companies achieve amazing milestones over four decades. It’s only fitting that the state’s thriving life sciences sector stop and recognize NCBiotech’s own milestone on the 40th anniversary of its founding ..read more

Milestone Pharmaceuticals, a Canadian company with a U.S. subsidiary in Charlotte, is back on track with a potential drug to treat rapid heart rates in certain cardiovascular disorders. The company in late March re-submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of etripamil for the management of paroxysmal supraventricular tachycardia (PSVT), a type of arrhythmia or abnormal heart rhythm.  ..read more

Gene therapy legend R. Jude Samulski, Ph.D., co-founder and chief scientific officer of Asklepios BioPharmaceutical (AskBio) since the company was established in 2001, is leaving the CSO job but remaining on the company board. AskBio announced that Mansuo Shannon, Ph.D., becomes CSO effective today. Shannon joins AskBio from Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, where she also served as CSO ..read more

FUJIFILM Diosynth Biotechnologies, a global contract development and manufacturing organization (CDMO), plans to invest $1.2 billion to double the size of its manufacturing facility currently under construction in Holly Springs. When completed, the site will be the largest end-to-end cell culture CDMO facility in North America, housing state-of-the-art biopharmaceutical manufacturing equipment and technology, including two large manufacturing suites for large-scale monoclonal antibody drug substance and drug product manufacturing.  ..read more